News

December 16, 2015
AbbVie to Present at the 34th Annual J.P. Morgan Healthcare Conference

NORTH CHICAGO, Ill., Dec. 16, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13, 2016. Richard A. Gonzalez, chairman and chief executive officer, will make a formal presentation on the company at 10:30 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at www.abbvieinvestor.com.  An archived edition of the session will be available later that day.  

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

 

SOURCE AbbVie

For further information: Media, Adelle Infante, (847) 938-8745, or Investors, Liz Shea, (847) 935-2211

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?